Oncodesign is a biopharmaceutical company dedicated to precision medicine. With its unique experience acquired by working with more than 1 000 clients along with its comprehensive technological platform combining state-of-the-art medicinal chemistry, pharmacology, bioanalysis, pharmaco-imaging & artificial intelligence, Oncodesign orients, drives & executes the development of drug candidates from hit findings up to early clinical phases.
Oncodesign has specialties in imaging and molecular radiotherapies (MRT).
Our expertise & capacities enable to provide imaging solutions to monitor your drug in order to better predict its efficacy. Our multimodal platforms are an open door for non-invasive techniques to understand the pharmacology of your compound.
Finally, we have a unique offering dedicated to pre-clinical evaluation of MRT: a unique combination of our skills in radiochemistry and in vivo pharmaco-imaging in order to assess radiotherapy efficacy.
Come discuss with our experts and find out about our capabilities!